Advice from a former regulator: Don’t let “deregulation” lull you into complacency
Nekia Hackworth, former SEC Deputy Director of Enforcement and DOJ Associate Deputy Attorney General, visited the Global Relay offices to share her thoughts on the government’s deregulatory stance and what compliance teams should look out for in an increasingly volatile risk landscape.
How to bring pharma sales reps’ communications into compliance
Pharma sales reps operate in high-pressure environments where they're judged on availability and responsiveness. Organizations have invested heavily in tools to support field teams, but that efficiency pressures creates a persistent temptation to cut corners on compliant communications.
Home health care provider pays $34 million after self-disclosing potential FCA violations
The settlement comes after Traditions Health submitted two self-disclosures of billing practices that potentially violated the Stark Law and Anti-Kickback Statute.
How will ChatGPT for Healthcare affect compliance operations?
Without clear guidelines on how to use generative AI tools, organizations must tread carefully to avoid compliance violations.
Has compliance outgrown traditional archiving?
Compliance teams are contending with more data, more regulatory pressure, and more advanced technology. To keep up, you need an archive that does more than just passively store data.
How can healthcare and life sciences organizations control GenAI recordkeeping risks?
With the use of generative AI tools like ChatGPT increasing within healthcare and life sciences organizations, how can businesses balance compliance and modernization while tapping into the benefits AI can offer?
How does Global Relay ensure data security?
From private encryption keys to Constant Integrity Checks and ISO certification, learn more about how Global Relay keeps data security locked down to keep your records secure, available, and tamperproof.
How does Global Relay ensure the long-term integrity of every message?
Constant Integrity Checking is a unique security measure developed by Global Relay to perpetually guarantee customer data is complete and untampered with.
What advice does the DOJ have for pharma compliance teams?
The DOJ assistant attorney general emphasized proactive self-disclosure and hinted at how pharmaceuticals can best prepare for new trends in enforcement.
Personal devices in crisis? Risks vs. rewards of BYOD policies in pharmaceuticals
Pharmaceutical companies face a tough choice between enabling BYOD or issuing corporate devices. Understand the risks, rewards, and compliance factors of both.
Regulatory Wrap Episode 71: FDA takes aim at pharma companies’ social media activity
In Regulatory Wrap for the week to October 3, Ryan Thaxton explores the growing spotlight on pharma companies’ social media activity.